Rare diseases
Investigational molecules
Locations
Back to France478 clinical trials in Bron, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A Study of Enlicitide for Safety and Effectiveness in Children and Adolescents with Heterozygous Familial Hypercholesterolemia
FranceA study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy
FranceA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
FranceTesting MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment
FranceStudy of oral cladribine compared to placebo for patients with generalized myasthenia gravis
FranceA study using MPPF imaging to examine serotonin pathways in the brainstem of patients with Dravet Syndrome epilepsy
FranceA study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis
FranceTesting Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease
FranceTesting zongertinib compared to standard treatment in patients with early-stage non-small cell lung cancer with HER2 mutations after surgery
FranceTesting a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection
FranceStudy of AEF0217 compared to placebo for improving behavior and thinking skills in adults and older adolescents with Down syndrome
FranceStudy of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple sclerosis and Parkinson's disease, including advanced PET imaging studies and evaluation of novel therapeutic approaches.
Studies include neuroinflammation assessment and serotonergic receptor expression analysis.
Comprehensive research into glioblastoma treatment approaches, combining innovative therapies with standard protocols.
Integration of radiotherapy, chemotherapy, and novel therapeutic agents for improved patient outcomes.
Targeted research on rare conditions including Dravet Syndrome and Alagille syndrome, focusing on innovative therapeutic approaches.
Emphasis on developing effective treatments for previously undertreated rare conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
